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Abstract
Background: Pili were recently recognized in Streptococcus pneumoniae and implicated in the
virulence of this bacterium, which led to the proposal of using these antigens in a future
pneumococcal vaccine. However, pili were found to be encoded by the rlrA islet that was not
universally distributed in the species. We examined the distribution of the pilus islet, using the
presence of the rlrA gene as a marker for the locus, among a collection of invasive isolates
recovered in Portugal and analyzed its association with capsular serotypes, clusters defined by the
pulsed-field gel electrophoretic profiles (PFGE) and multilocus sequence types.
Results: Only a minority of the isolates were positive for the presence of the rlrA gene (27%).
There was a high correspondence between the serotype and the presence or absence of rlrA
(Wallace coefficient, W = 0.778). In particular, there was an association between the presence of
rlrA and the vaccine serotypes 4, 6B, 9V and 14 whereas the gene was significantly absent from other
serotypes, namely 1, 7F, 8, 12B and 23F, a group that included a vaccine serotype (23F) and
serotype 1 associated with enhanced invasiveness. Even within serotypes, there was variation in the
presence of the pilus islet between PFGE clones and a higher Wallace coefficient (W = 0.939)
indicates that carriage of the islet is a clonal property of pneumococci. Analysis of rlrA negative
isolates revealed heterogeneity in the genomic region downstream of the rfl gene, the region where
the islet is found in other isolates, compatible with recent loss of the islet in some lineages.
Conclusion: The pilus islet is present in a minority of pneumococcal isolates recovered from
human invasive infections and is therefore not an essential virulence factor in these infections.
Carriage of the pilus islet is a clonal property of pneumococci that may vary between isolates
expressing the same serotype and loss and acquisition of the islet may be ongoing.
Background
Non-flagellar polymeric cell-surface organelles designated
as pili were initially identified in Gram-negative bacteria.
In the last decade, pilus-like surface structures have been
described in Gram-positive bacteria like Corynebacterium
spp., Actinomyces spp. and several streptococcal species [1],
but only recently were pili identified in the major patho-
genic species of the genus: Streptococcus pyogenes, Lancefield
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group A [2]; Streptococcus agalactiae, Lancefield group B [3]
and Streptococcus pneumoniae (pneumococcus) [4].
In S. pneumoniae pili are encoded by the rlrA pathogenicity
islet, a 14.2 kb region composed of 7 genes encoding a
putative transcriptional regulator (RlrA), 3 LPXTG surface
proteins with weak homology to microbial surface com-
ponents recognizing adhesive matrix molecules –
MSCRAMMs (RrgA, RrgB and RrgC) and 3 sortases (SrtB,
SrtC and SrtD) [4-6]. Pneumococcal pili have the appear-
ance of flexible rods ranging from 0.3 μm to 3 μm that are
formed by a transpeptidase reaction involving sortase-
mediated covalent cross-linking of the proteins contain-
ing the LPXTG-like motif and several lines of evidence
suggest a one-to-one sortase-to-surface-protein corre-
spondence for the proteins encoded by the islet [7].
The  rlrA  gene was identified in the original signature
tagged mutagenesis study as an essential virulence gene in
murine models of infection [5]. Later studies confirmed
that the RlrA protein acted as a transcription factor recog-
nizing several promoters within the rlrA islet and showed
it to be essential for wild-type levels of expression of the
pili structural genes and associated sortases [6]. The prod-
uct of the mgrA gene, located outside the rlrA islet, was
shown to act as a transcriptional repressor of the islet
genes, including rlrA, being responsible for the silencing
of the locus in the absence of RlrA [8].
The presence of the rlrA pathogenicity islet was shown to
influence pneumococcal capacity to adhere to human
lung epithelial cells [4,8]. Mouse models of pneumococ-
cal pneumonia and bacteremia have also suggested a role
of pili in virulence and host inflammatory responses [4,5].
More recently, immunization of mice with pilus structural
antigens was shown to induce protection against lethal
challenge by piliated strains [9]. Moreover, these studies
indicate that vaccination with the pilus subunits offers the
same protection as vaccination with heat killed bacteria,
raising the possibility of using pilus antigens in a multiva-
lent pneumococcal vaccine [9].
In spite of these favorable results, early genomic studies
indicated that the rlrA islet was not present in all pneumo-
coccal isolates, suggesting that it could have been acquired
by horizontal gene transfer [10] and raising a cautionary
note concerning the use of pilus antigens in any future
vaccine. A survey for the distribution of the sortase genes
identified the srtA gene in all tested bacteria, but the sor-
tases associated with the rlrA islet were present in only
17% of the isolates tested [11]. A recent study, specifically
designed to evaluate the distribution of the rlrA  islet
among pneumococcal isolates associated with coloniza-
tion and infections in Native Americans, found that only
21% of the isolates were positive for rrgC, a gene encoding
a pilus structural protein, and that there was an associa-
tion between the presence of this gene and the serotypes
included in the seven-valent conjugate vaccine [12]. How-
ever, the same study could not show a difference in the
presence of rrgC between the isolates recovered from the
nasopharynx and those recovered from sterile sites. In
contrast, the mgrA  gene encoding the transcriptional
repressor of the rlrA islet seems to be universally distrib-
uted within S. pneumoniae [8].
In view of these findings, a better understanding of the
distribution of the pilus islet in the invasive pneumococ-
cal population will help in the evaluation of its proposed
role as a virulence factor and as a potential vaccine candi-
date. In the present study, we determined the prevalence
of the rlrA gene in a recent collection of invasive isolates
from both children and adults with the aim of identifying
associations between the presence of the pilus islet and
serotype, antimicrobial resistance or clonal types defined
by pulsed-field gel electrophoresis (PFGE) and multilocus
sequence typing (MLST).
Results
Distribution of the rlrA islet among invasive pneumococci
Only a small portion (27%) of our invasive isolates was
rlrA positive and a total of 355 (73%) isolates were found
to lack the pilus islet by Southern blot hybridization and
PCR amplification of the rlrA  gene (Additional file 1:
Southern hybridization of a representative set of isolates
with the rlrA gene probe.). A group of 39 isolates repre-
sentative of the diversity found among the rlrA positive
isolates (n = 128) was subject to long-range PCR. All iso-
lates yielded fragments larger than 14 kb compatible with
the presence of the entire pilus locus (data not shown),
confirming that the presence of the rlrA gene is a good
marker for the presence of the entire pilus islet.
Overall rlrA positive isolates were found in 11 serotypes of
the 41 serotypes in our collection (Additional file 2: Char-
acteristics of the clones where the pilus locus was identi-
fied.). Isolates expressing serotypes 1, 3, 4, 6A, 6B, 9V, 13,
14, 19A, 19F, 35B were shown to carry the rlrA gene as
well as non-typable isolates, but 83% of the rlrA positive
isolates expressed vaccine serotypes (4, 6B, 9V, 14, and
19F). The proportion of isolates carrying the pilus islet
among isolates of the same serotype was variable (Figure
1), but overall serotype was a good predictor of the pres-
ence or absence of the pilus islet, as indicated by the high
Wallace coefficient (W = 0.778).
Although there were differences in the overall proportion
of isolates carrying the pilus islet between the isolates
recovered from children < 6 yrs. old (37%) and from
adults (24%) (p = 0.026), we could not shown differences
between the two age groups when we considered the pro-BMC Microbiology 2008, 8:41 http://www.biomedcentral.com/1471-2180/8/41
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portion of rlrA positive isolates stratified by serotype using
the Mantel-Haenszel test (p = 0.200), indicating that the
overall disparity is due to a different distribution of sero-
types in the two age groups.
In order to identify which serotypes were associated with
the presence of the rlrA islet, odds ratios were calculated.
An OR > 1 implies that the serotype is associated with the
presence of rlrA, while an OR < 1 indicates that the sero-
type is significantly depleted of rlrA  positive isolates.
According to this analysis, serotypes 4, 6B, 9V and 14 were
highly associated with the presence of the pilus islet (p <
0.01 for all serotypes). On the other hand, the rlrA islet
was significantly absent from serotypes 1, 7F, 8, 12B and
23F (Table 1).
Association between the presence of the pilus islet and 
resistance to antimicrobials
A clear correlation between the presence of rlrA and anti-
microbial resistance was noted. We found that most iso-
lates carrying the pilus islet were resistant to at least one
antimicrobial – 54% (69/128) were non-susceptible to
penicillin, 18% (23/128) were resistant to erythromycin
and 17% (22/128) were multi-resistant. This association
was further confirmed since the OR calculated for resist-
ance to individual antibiotics and the presence of the pilus
islet were mostly > 1 and significant (Table 2).
Presence of the pilus islet is a clonal property
Characterization of the genetic lineages of the pneumo-
coccal collection included in the present study had been
performed previously [13]. Analysis by genetic lineage of
the isolates demonstrated that the presence of the rlrA islet
was not only associated with serotype but also with PFGE
cluster within each serotype, defined as described previ-
ously [13] (Additional file 2 – Characteristics of the clones
where the pilus locus was identified – and Additional file
3 – Characteristics of the bacterial clones not associated
with the pilus locus). The Wallace coefficient relating the
PFGE clusters with the presence or absence of rlrA (W =
0.939) was higher than for serotype (W = 0.778) indicat-
ing that the pathogenicity islet is clonally distributed. The
value of the Wallace coefficient indicates that only one out
of 20 pairs of isolates grouped in the same PFGE cluster
will differ in the presence of the rlrA islet in their genome.
Frequency of the rlrA islet among serotypes in which at least  one rlrA positive isolate was found Figure 1
Frequency of the rlrA islet among serotypes in which 
at least one rlrA positive isolate was found. Black bars 
indicate the number of isolates positive for the presence of 
the rlrA islet. White bars indicate the number of isolates neg-
ative for the presence of the rlrA islet.
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Table 1: Association of the rlrA islet with serotypes and PFGE clusters
Serotype OR (95% CI)a p STs in PFGE clus-
terb
OR (95% CI) p
1 0.22 (0.07 – 0.53) 0.0011 [ST306 + ST228] 0.079 (0.01 – 0.59) 0.0007
3N S c [ST1220 + ST260] + 
[ST1230 + ST180]
0.06 (0.01 – 0.44) < 10-4
4 12.74 (5.05 – 32.12) < 10-4 ST1221 80.26 (4.72 – 1363.4) < 10-4
ST247 30 (3.8 – 236.84) < 10-4
6B 7.44 (2.29 – 24.16) 0.0005 ST1224 + ST273 47.33 (2.7 – 830.37) < 10-4
7F 0 (0 – 0.61) 0.0052 ST191 0 (0.0 – 0.70) 0.0089
8 0 (0 – 0.37) 0.0002 ST53 0 (0.0 – 0.57) 0.0057
9V 14.36 (4.76 – 43.33) < 10-4 [ST156 + ST557 + 
ST644 + ST1225]
16.76 (4.80 – 58.54) < 10-4
12B 0 (0 – 0.70) 0.0089 NSc NSc
14 16.13 (8.50 – 30.63) < 10-4 [ST156 + ST557 + 
ST790]
212.4 (28.89 – 1561.8) < 10-4
23F 0 (0 – 0.44) 0.0006 ST338 + ST1371 0 (0.0 – 0.57) 0.0057
aAn OR of > 1 indicates increased proportion of rlrA positive isolates whereas OR of < 1 indicates decreased proportion of rlrA positive isolates. 
Only statistically significant results (FDR < 0.05) are presented.
bSTs in PFGE clusters with a Dice similarity coefficient of > 80%. Brackets indicate STs that belong to the same lineage, as defined by eBURST 
analysis with the complete S. pneumoniae database available at spneumoniae.mlst.net. Only statistically significant results (FDR < 0.05) are presented.
cNS – not significantBMC Microbiology 2008, 8:41 http://www.biomedcentral.com/1471-2180/8/41
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To verify if there were PFGE clusters associated with the
presence of rlrA, odds ratios were determined and the sig-
nificant values obtained in this analysis are indicated in
Table 1. In some serotypes identified as associated with
the presence of the pilus islet, all of the major PFGE clus-
ters showed also a positive association with the presence
of rlrA (serotype 4, table 1 and Additional file 2: Charac-
teristics of the clones where the pilus locus was identi-
fied.), but in others only some of the PFGE clusters were
associated with rlrA (serotype 14, table 1 and Additional
file 2: Characteristics of the clones where the pilus locus
was identified). The fact that the presence of the rlrA islet
is a clonal property is further illustrated by isolates of sero-
type 3, that is not itself significantly associated with the
presence nor with the absence of the rlrA islet, but a clone
expressing serotype 3 was found to be significantly
depleted of the pilus islet (table 1). Note that the OR val-
ues are more extreme when compared with the values cal-
culated for serotype alone, further supporting the notion
that the presence of the pilus islet is a clonal property.
Prior work from our group showed that there is a close
correspondence between PFGE cluster and ST [13]. The
relationships between sequence types have been explored
by various methodologies, including eBURST [14] that
was specially developed to analyze MLST data and is fre-
quently used to define clonal complexes. An eBURST
analysis revealed that all isolates carrying the pilus islet
expressing serotypes 9V and 14, which represented 54%
(69/128) of the total isolates positive for rlrA, were clon-
ally related and represented clone Spain9V-3 (ST156) [15]
(Additional file 2: Characteristics of the clones where the
pilus locus was identified.). Another association of the
presence of the pilus islet and PMEN clones was observed
in serotype 6B where all seven isolates belonging to a
PFGE cluster represented by ST1224 and ST273 and a sin-
gle isolate in a different PFGE cluster, but also exhibiting
ST273, were all positive for the presence of rlrA and are
related to clone Greece6B-22 [16] (Additional file 2: Char-
acteristics of the clones where the pilus locus was identi-
fied.). On the other hand, among serotype 14 isolates
related to England14-9 (PFGE cluster represented by ST15
and ST409), and serotype 6B isolates related to Poland6B-
20 (PFGE cluster characterized by ST887), no isolates car-
rying the pilus islet could be found.
Characterization of rlrA negative isolates
The majority of the isolates were negative for the presence
of the rlrA gene (n = 355). To explore the possibility that
the rlrA negative isolates still retained parts of the patho-
genicity islet, a PCR was performed using a set of primers
that flanked the whole islet (Figure 2B and 2C, primers
PFL-up and P-dn). All isolates yielded a PCR product and
the majority (283 isolates, 80%) originated a product
with the same size as strain R6 (Figure 2A, lanes 2 and 4
and figure 2C). The remaining 72 (20%) isolates revealed
larger amplification products: 68 presented a product des-
ignated type C (figure 2A, lane 3 and figure 2C), while the
remaining 4 presented a product designated type B (Figure
2A, lane 1 and figure 2B). In order to determine the
genetic differences responsible for the heterogeneity in
size of the PCR products, a representative isolate of types
B and C was sequenced. The genetic makeup of the vari-
ous regions is illustrated in figures 2B and 2C.
Both the type B and C regions, contain DNA stretches sim-
ilar to those found in the 3' region of the rlrA locus of
strain TIGR4. These common DNA elements were found
to be similar to the region found upstream of the rlrA
locus of TIGR4 encoding the IS1167 transposase however,
due to mutations and indels, these are no longer capable
of producing a full-length functional protein. BLAST
searches demonstrated a high number of similarly
degraded copies of the IS1167 transposase distributed
throughout the available complete genomes of strains of
Streptococcus pneumoniae (TIGR4, R6 and D39). There is
Table 2: Association of the rlrA islet with antimicrobial resistance
Antibiotic no. rlrA positive strains/
no. resistant isolates (% 
rlrA positive strains)
no. rlrA positive strains/
no. susceptible isolates 
(% rlrA positive strains)
OR(95% CI)a p
Penicillinb 69/113 (61) 59/370 (16) 8.27 (5.17 – 13.22) < 10-4
Erythromycin 23/48 (48) 105/435 (24) 2.89 (1.58 – 5.30) 0.0004
Tetracycline 16/38 (42) 112/445 (25) 2.16 (1.09 – 4.26) 0.023
Chloramphenicol 5/14 (36) 123/469 (26) NSc
Co-trimoxazole 74/106 (70) 54/377 (14) 13.83 (8.35 – 22.91) < 10-4
MDRd 22/42 (52) 106/441 (44) 3.48 (1.83 – 6.62) < 10-4
aAn OR of > 1 indicates increased proportion of rlrA positive isolates whereas OR of < 1 indicates decreased proportion of rlrA positive isolates. 
Only statistically significant results (FDR < 0.05) are presented.
b Both penicillin intermediate and fully resistant isolates were considered resistant for this analysis
cNS – not significant
dMDR – multidrug resistance defined as resistance to at least three different antimicrobial classes considering as resistant to penicillin both 
intermediate as well as fully resistant isolatesBMC Microbiology 2008, 8:41 http://www.biomedcentral.com/1471-2180/8/41
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The genetic structure of the region downstream of the pfl gene where the rlrA islet is found among piliated isolates Figure 2
The genetic structure of the region downstream of the pfl gene where the rlrA islet is found among piliated iso-
lates. Panel A. Agarose gel of the PCR products resulting from the amplification of the region downstream of the pfl gene 
using primers PFL-up and P-dn. m – DNA ladder (1 kb plus, Invitrogen, Carlsbab, CA). Lane 1 – isolate presenting a region type 
C. Lane 2 – isolate presenting a region type A. Lane 3 – isolate presenting a region type B. Lane 4 – strain R6. Sizes of the frag-
ments in kilobases are indicated in the left. Panel B. Structure of the region found downstream of the pfl gene in four isolates 
and designated region type B compared to the rlrA islet and flanking regions of strain TIGR4. Genes are indicated by arrows 
and primers by vertical lines. Genes encoding proteins with similar functions are represented by the same pattern. The frag-
ments with high DNA similarity between the regions compared are represented by black and grey boxes connected by lines 
(analysis was performed using the GATA software). Panel C. Structure of the region found downstream of the pfl gene in 68 
isolates and designated region type C compared to the corresponding region of strain R6 (region type A).
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a high identity between the IS1167 degraded transposase
sequence found downstream of the rlrA locus in TIGR4
and the one found in the type B region (97% identity in
the 1277 nt aligned, with only two single nucleotide
gaps). The similarity extends to other coding and non-
coding regions found between srtD and spr0470 of TIGR4
(Figure 2B). This observation is compatible with the
hypothesis that region type B was generated by the recent
loss of the rlrA islet. Further supporting this notion is the
observation that this region was found exclusively among
the few isolates not carrying the pilus islet among large
PFGE clusters of rlrA positive isolates (Additional file 2:
Characteristics of the clones where the pilus locus was
identified.).
The DNA sequence corresponding to the degraded copy of
the IS1167 transposase in region type C differed more
extensively from the two discussed above, namely by a 50
nt insertion and a 16 nt deletion. A comparison of the
type C region with the corresponding sequence of strain
R6 revealed extensive similarity, including the presence of
ORF CDS137 and a downstream repeat region found in
strain R6 but absent from the pilus locus in strain TIGR4
(Figure 2C). The type C region is therefore closely related
to the one found in strain R6 with the exception of the
presence of a degraded copy of the IS1167 transposase,
suggesting that the region downstream of the pfl gene may
constitute a hotspot for recombination events. The type C
region was found associated with specific PFGE clusters
expressing a limited number of serotypes (Additional file
2 – Characteristics of the clones where the pilus locus was
identified – and Additional file 3 – Characteristics of the
bacterial clones not associated with the pilus locus.), but
this was not an exclusive association since isolates pre-
senting regions type A and C were frequently grouped in
the same PFGE cluster. For instance, the largest PFGE clus-
ter in serotype 3 contains almost equal numbers of iso-
lates presenting each of the regions.
Discussion
The long-term efficacy of the seven-valent conjugate vac-
cine is being challenged by the emergence of infections
caused by replacement serotypes not targeted by the vac-
cine. The difficulty in producing higher valency vaccines
and the realization that any polysaccharide based vaccine
may be ultimately limited in its efficacy, due to the large
number of pneumococcal capsular types, prompted the
search for other vaccine targets. Recently, the three struc-
tural proteins constituting pneumococcal pili were shown
to protect mice against invasive infections and were pro-
posed as potential vaccine candidates [9].
The data presented here argues that the efficacy of such a
vaccine would be limited by the small proportion of iso-
lates carrying the pilus islet (27%) and therefore poten-
tially expressing pili, among those causing invasive
infections in humans. The strong association of the rlrA
islet with four of the seven serotypes included in the con-
jugate vaccine would further limit the advantages of a
pilus component vaccine over the one currently availa-
ble. Recently, Basset et al. explored the distribution of
the rlrA islet, using rrgC as a marker for the presence of
the pilus locus [12]. The population analyzed by Basset
et al. differed markedly from the one analyzed here by
including a large fraction of isolates associated with col-
onization, a different distribution of serotypes and, most
importantly, the genetic makeup of the pneumococcal
population was strikingly different with only 15 com-
mon STs out of the 158 STs identified overall in the two
collections. In spite of these differences, a surprisingly
similar proportion of isolates carrying the pilus islet was
found among invasive isolates by Basset et al. (24%, n =
123). Taken together the results of the two studies sug-
gest that the pilus does not represent an essential viru-
lence factor for invasive disease in humans, in contrast to
previous indications from mouse models [4,5]. This sug-
gestion receives further support from the observation
that the same fraction of isolates associated with asymp-
tomatic carriage were positive for the pilus islet [12].
The collection characterized here was previously ana-
lyzed for the phase variant expressed by the isolates [17],
another phenotype implicated in enhanced invasive-
ness. A proportion of opaque variants similar to the one
positive for the rlrA gene was found (26%), prompting
us to evaluate the association between opacity and the
pilus islet. However, no association could be shown
between the opacity phenotype of a given isolate and
carriage of the pilus islet. In fact, two serotypes found to
be associated with predominantly opaque variants, sero-
type 1 and 4 [17], were found to be significantly depleted
of isolates positive for rlrA and strongly associated with
the presence of the islet, respectively.
A prior study emphasized the higher prevalence of the
pilus islet among the serotypes included in the currently
available conjugate vaccine versus all other serotypes
[12]. Here we expand these findings by identifying which
serotypes are particularly enriched or depleted in the
presence of the pilus locus. Specifically, among the seven
serotypes included in the conjugate vaccine, although
most serotypes are indeed associated with the presence
of the pilus locus (4, 6B, 9V and 14), serotype 23F was
significantly depleted of the presence of this locus, indi-
cating that an association with the presence of the pilus
locus is not a property of all vaccine serotypes, while
serotypes 18C and 19F did not reach statistical signifi-
cance. Interestingly, while vaccine-serotype 14 was asso-
ciated with the presence of the pilus islet in the present
study, the islet was found in less than 10% of the isolatesBMC Microbiology 2008, 8:41 http://www.biomedcentral.com/1471-2180/8/41
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expressing this serotype among a collection of North
American isolates [12]. This discrepancy is possibly due
to differences in the genetic structure of this serotype in
the two collections, as discussed below, and highlights
the pitfalls of establishing an association between the
presence of the pilus locus and serotype without consid-
eration for the clonal structure of the bacterial popula-
tion expressing a particular serotype. It is also
noteworthy that serotype 1, previously identified as hav-
ing enhanced invasive disease potential [18], was signif-
icantly depleted of isolates carrying the pilus islet (table
1) in contrast to the proposed role of pili as virulence
potentiators.
We could also show an association between the presence
of the pilus islet and resistance to several antimicrobials,
including penicillin (table 2). Such an association was
expected since the serotypes where the pilus islet was
found also concentrate the majority of resistant isolates.
Recently, pili were suggested to play an important role in
the dissemination of penicillin non-susceptible isolates
in Sweden [19]. The clonal lineage implicated in Sweden
was represented by ST156 that was also found to be sig-
nificantly associated with the presence of the pilus islet
in our collection, independently of the serotype
expressed by the isolates (serotype 9V or 14, table 1).
An analysis of the genetic backgrounds of the isolates
showed that the best predictor of the presence of the
pilus islet was the PFGE cluster, independently of the
serotype, indicating that this is a clonal property. Partic-
ularly interesting, is the fact that different lineages
expressing the same serotype can be associated with the
presence or absence of the locus, which may confound
an analysis of association of the pilus islet with serotype
only disregarding the clonal structure of the population.
For instance, among the isolates expressing serotype 14,
the dominant lineage characterized by ST156 and related
STs was associated with the presence of the pilus locus in
a serotype independent analysis (table 1). However, in
the second most prevalent lineage expressing serotype
14, characterized by ST15 and related STs, the locus is
conspicuously absent (Additional file 2: Characteristics
of the clones where the pilus locus was identified.). A dif-
ferent clonal structure could thus explain the low preva-
lence (< 10%) of the pilus locus in serotype 14 in the
report of Basset et al. [12] that is in sharp contrast with
the high prevalence of the locus in this serotype found in
our collection (78%, Additional file 2: Characteristics of
the clones where the pilus locus was identified.). Impor-
tantly, we also show that some PFGE clusters are signifi-
cantly depleted in isolates carrying the pilus locus and,
since these were the dominant clones among their sero-
types, a significant depletion at the serotype level was
also evident in most cases (table 1). The only exception
was serotype 3 where, in spite of the presence of a dom-
inant clone significantly depleted of the pilus locus, the
presence of a minor cluster represented by ST458 consti-
tuted exclusively by isolates positive for the pilus islet
prevented the association at the serotype level to reach
significance. The existence of clones expressing the same
serotype associated or depleted in the pilus islet raises
the possibility that in other geographic areas with a dif-
ferent clonal structure, the association between particu-
lar serotypes and the presence or absence of the pilus
locus may be different from the one reported here.
A prior study had suggested a strong association between
the PMEN clones and the presence of the pilus islet [12].
In the present collection, the Spain9V-3 clone was found
to be strongly associated with the presence of the pilus
islet similarly to what was found previously [12,19], but
other PMEN clones found in our collection were devoid
of isolates positive for rlrA  such as England14-9 and
Poland6B-20, so that carriage of the pilus locus is not a
universal property of widely disseminated lineages.
Basset et al. discuss the limitations of using the detection
of rrgC by PCR as a marker for the presence of the pilus
islet [12]. One of the concerns is that this may have been
a too broad criterion in that strains that carry the rrgC
gene may lack other genes essential for pilus expression.
Although our study suffers from the same limitation, the
long-range PCR performed on a subset of the isolates
positive for the rlrA gene yielded products whose sizes
were compatible with the presence of the entire locus, in
agreement with previous studies that indicated that the
rlrA islet is either present or absent in its entirety [12,19].
However, the primary concern of Basset et al. was that
theirs could have been a too stringent criterion, since
strains not containing the rrgC gene or negative by PCR
due to variability in this structural gene may still express
pili. Our choice of using the presence of rlrA to define
piliated isolates was designed to avoid these problems.
RlrA is a regulatory protein and it is therefore expected to
be more conserved than a structural protein and the pres-
ence of this protein was shown to be essential for wild-
type levels of expression of the pilus structural genes and
associated sortases [6], indicating that isolates lacking
this gene would also be impaired in pilus expression.
Moreover, the PCR performed using primers targeting
conserved DNA regions flanking the rlrA locus conclu-
sively showed that all strains lacking the rlrA gene also
lacked all the sortases and structural genes necessary for
pilus biosynthesis. Therefore, the 27% of invasive iso-
lates containing the rlrA  gene constitute the fraction
genetically equipped to express pili, although only the
availability of specific antibodies targeting the pilus
could determine if this genetic potential was fully
realized.BMC Microbiology 2008, 8:41 http://www.biomedcentral.com/1471-2180/8/41
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The study of the rlrA negative isolates revealed different
genetic organizations of the region where the pilus islet
is usually found, suggesting that this region may be a
hotspot for DNA insertions and deletions. Transposons
and IS elements have been shown to be a frequent cause
of duplications and deletions in bacterial chromosomes
through homologous recombination [20]. Significantly,
the sequence of the IS1167 transposase retained in the 3'
region of the pilus locus is severely altered when compar-
ing to the one in the 5' region (fig. 2) which may hinder
homologous recombination and stabilize the presence
of the pilus locus. Notwithstanding, the distribution and
genetic arrangement of region type B, with the presence
of CDS283 that was exclusively associated with the pilus
locus, suggests that it may have resulted from the recent
loss of the pilus islet in some lineages, possibly through
intra-chromosomal homologous recombination
between the conserved 3' regions of the flanking IS1167
transposase encoding segments or through an error in
excision mediated by a functional IS1167 transposase,
such as the one putatively encoded in the 5' region of the
locus. A recombination event would be expected to
retain most of the 3' copy of the IS1167 transposase and
the downstream region as was indeed verified (Fig. 2).
The DNA sequence of the type C region, that differs from
the more common type A region found in strain R6 by
the presence of a degraded IS1167 transposase encoding
segment, offers limited clues as to its origin. However,
the presence of an IS1167 sequence could further pro-
mote the acquisition of the pilus islet by providing a
region of sequence similarity that could facilitate homol-
ogous recombination.
Carriage of the pilus islet was shown to be a clonal prop-
erty and its association with a widely disseminated pneu-
mococcal clone (Spain9V-3), may indicate that pili could
facilitate dissemination or colonization of the host, as
suggested recently [19]. The pneumococcal population
included in our study was obtained from a period prior
to the introduction of the heptavalent vaccine [13,21].
Since the majority of the isolates positive for the pilus
locus expressed vaccine serotypes, a decrease of piliated
strains due to vaccine introduction, which was already
observed in the USA [12], might be expected. However,
some serotypes that are emerging due to vaccine pres-
sure, such as 19A [22,23], include clones that carried the
rlrA islet and the diversity of the region associated with
the pilus locus suggests that loss and acquisition of the
islet may be ongoing. Since serotype prevalence is
changing as a consequence of vaccine introduction
[22,23] the acquisition of the pilus locus by the emerging
clones or the increase in incidence of piliated clones may
shed light on the role of this surface structure in human
infections.
Conclusion
The low prevalence of the rlrA islet in our collection of
invasive isolates indicates that the pilus does not represent
an essential virulence factor in human infections and that
its potential use in a vaccine would offer limited benefits.
Carriage of the pilus islet was shown to be a clonal prop-
erty that may vary between isolates expressing the same
serotype. The variable nature of the region downstream of
the pfl gene in isolates lacking the pilus islet suggests that
acquisition and loss of the islet may be ongoing.
Methods
Bacterial isolates
A collection of 465 invasive pneumococcal isolates recov-
ered during the years of 1999 to 2002 in Portugal were
previously described [21]. Additionally, 18 invasive iso-
lates, recovered during the same period, were added to our
collection and further characterized (total n = 483).
Briefly, 87 isolates were recovered from children < 6 yrs.
and 381 from adults (≥ 18 yrs). Overall, serotypes 14, 1,
3, 4, 8, 9V, 23F, 7F, 19A and 12B were the most prevalent
by decreasing rank order. The isolates were characterized
by a combination of macrorestriction profiling using the
SmaI endonuclease and pulsed-field gel electrophoresis
(PFGE) and multilocus sequence typing (MLST) [13]. The
isolates were analyzed separately by serotype and PFGE-
based clusters were defined as isolates with ≥ 80% related-
ness on an UPGMA dendrogram constructed using the
Dice coefficient. MLST analysis was performed for at least
one isolate in each major PFGE cluster (n = 127) and
revealed 66 different sequence types (ST) corresponding
to 47 different lineages by eBURST analysis [13]. Impor-
tantly, a comparison of the clones found in this collection
with those found in the United States by Gertz et al. [24]
showed that only 11 lineages, as defined by MLST, were
common out of a total in excess of 150 STs identified in
the two studies. Similarly, a comparison with the study of
Basset et al. [12] revealed that only 15 out of the 158 STs
identified overall in the two studies were common.
The reference strains TIGR4 [10] and R6 [25] were used as
positive and negative controls for the presence of the pilus
islet.
Detection of the rlrA islet
Identification of isolates carrying the rlrA islet was per-
formed by southern blot hybridization. Genomic DNA
from  S. pneumoniae was prepared in agarose plugs as
described previously, digested with SmaI and separated by
PFGE in a CHEF-DR II apparatus (Bio-Rad Laboratories,
USA) [13]. Following electrophoresis, the DNA was trans-
ferred to nylon membranes (Hybond-N+, Amersham Bio-
sciences, Bucks, UK) with a VacuGene system (Pharmacia
Biotech AB, Uppsala, Sweden) and subjected to Southern
hybridization under stringent conditions. The probe wasBMC Microbiology 2008, 8:41 http://www.biomedcentral.com/1471-2180/8/41
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constructed using primers RLRA-up (5'-TCT GAT AGA
TGA GAC GCT GTT G-3') and RLRA-dn (5'-CTC CGC TTC
TTT CTA CTA CAA G-3'), which allowed the amplification
of an 1177 bp internal fragment of the rlrA gene using
DNA from strain TIGR4 as template (Figure 2B). Labeling
and hybridization were performed using ECL direct
nucleic acid labeling and detection system (GE Health-
care, Buckinghamshire, UK), according to the instructions
of the manufacturer. The molecular size of the hybridiza-
tion signals and the corresponding SmaI fragments were
determined.
For some isolates hybridization yielded ambiguous
results, possibly due to problems during blotting of the
DNA onto the nylon membranes or degradation of the
membranes during storage. In these cases, the rlrA gene
was detected by PCR, using RLRA-up and RLRA-dn prim-
ers. Template DNA was prepared by diluting 9 μl of an
overnight culture in 441 μl of water and boiling of this
mixture for 2 min. The PCR reactions were performed in a
50 μl volume containing 20 μl of template solution, 1×
reaction buffer (Biotools, Madrid, Spain), 1.25U Tth DNA
polymerase (Biotools, Madrid, Spain), 10 mM dNTPs
(Fermentas, Vilnius, Lithuania) and 20 pmol of each of
the primers. The PCR program consisted of 30 cycles of
95°C for 30 s, 55°C for 30 s, and 72°C for 30 s, followed
by 10 min incubation at 72°C.
Characterization of the chromosomal region where the 
rlrA islet is usually found in non-piliated strains
In order to confirm that the rlrA negative strains did not
carry the pilus pathogenicity islet or parts of it, a set of
primers that flanked the rlrA  pathogenicity islet were
developed – PFL-up (5'-ATC TCA TTG ACT ACA CAA GTA
TCA CCT C-3') and P-dn (5'-CAA GAG CAT ACT CCA ACT
CAT AAA TAT GTG-3') – with the aim of amplifying the
entire pilus islet (Figure 2B and 2C). All strains that were
negative for the presence of the rlrA gene were subject to
PCR with primers PFL-up and P-dn, as well as TIGR4 (pil-
iated control), and R6 (non-piliated control). If the pilus
islet or parts of it were absent, the PCR product expected
using these primers would be similar to that obtained
when using R6 DNA as template (1310 bp). The PCR reac-
tions were performed in a 50 μl volume containing 20 μl
of template solution, 1× reaction buffer (Biotools,
Madrid, Spain), 1.25U Tth DNA polymerase (Biotools,
Madrid, Spain), 10 mM dNTPs (Fermentas, Vilnius,
Lithuania) and 20 pmol of each of the primers. The PCR
program consisted of 30 cycles of 95°C for 30 s, 60°C for
30 s, and 72°C for 3 min, followed by 10 min incubation
at 72°C. Whenever no PCR product was obtained using
these conditions, and in a subset of the isolates positive
for the rlrA gene representing the diversity found within
the collection, the reaction was performed in conditions
allowing the amplification of fragments larger than 10 kb.
In this case DNA was extracted using CTAB [26] and the
PCR reaction was prepared using the Expand Long Tem-
plate PCR System (Roche, Mannheim, Germany) accord-
ing to the manufacturers instructions. The PCR program
consisted of incubation at 94°C for 2 min followed by 10
cycles of 94°C for 10 s, 58°C for 30 s, and 68°C for 13
min, and 20 cycles of 94°C for 15 s, 58°C for 30 s, and
68°C for 13 min with an incremental increase of 20 s per
cycle, followed by 7 min incubation at 68°C.
Strains representative of the various sizes of PCR products
obtained were sequenced by primer walking. The
sequences were compared using BLAST against the availa-
ble sequence databases at the NCBI to identify similar
sequences and to each other using the MEGA [27] and
GATA [28] software programs.
Statistical analysis
Wallace coefficients (W) were used to compare partitions.
This coefficient indicates the probability that two isolates
sharing the same characteristic by a given typing method
will also be grouped together by a different typing method
[29]. In this study, Wallace coefficients were used to esti-
mate the power of a given typing method in predicting the
presence or absence of the pilus locus.
Statistical associations between the presence of the rlrA
islet and serotype, PFGE cluster or antimicrobial resist-
ance profile were characterized by odds ratios (OR) with
95% Wald confidence intervals (CI) [30]. For null OR,
95%CI were computed through the Fisher method [31].
OR significance or statistical differences between propor-
tions were tested with the chi-square statistic. The result-
ing p-values were corrected for multiple testing by
controlling the False Discovery Rate (FDR) under or equal
to 0.05 through the linear procedure of Benjimini and
Hochberg [32]. Difference in proportion of rlrA islet pres-
ence in isolates recovered in different age groups, stratify-
ing for serotype was evaluated with the Mantel-Haenszel
test [33]. The p-values indicated in the text were consid-
ered significant if lower than 0.05.
Wallace coefficient analysis was done in a web application
[34] and the remaining statistical tests were executed in
the R statistical language using functions implemented in
the epitools package [35].
Nucleotide sequence accession numbers
The sequences of isolates representing the various sizes of
the PCR products obtained in rlrA negative isolates were
deposited in GenBank with accession numbers EU126839
and EU126840.BMC Microbiology 2008, 8:41 http://www.biomedcentral.com/1471-2180/8/41
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